> Home
 
  > About
 
  > Portfolio
 
  > News
 
  > Documents for download
 
  > Investors
 
  > Press Room
 
  > Policies and Ethics
 
  > Contact
 
  > Links


Karolinska Development
AB (publ)
org. nr. 556707-5048
Registered office: Solna
© Karolinska Development 2008

 

 

Independent Pharmaceutica AB

The company develops new treatment methods against nicotine addiction based on new vaccine technology and innovative pharmacological approaches.

Contact
Lena Degling Wikingsson, CEO
  +46 8 508 84 493
 
  www.independentpharma.com

 

 

  
 

Actar AB
Akinion Pharmaceuticals AB
Aprea AB
Athera Biotechnologies AB
Avaris AB
Axelar AB
BioArctic Neuroscience AB
BioChromix Pharma AB
Biocis Pharma Ltd.
Bioneris AB
BioResonator AB
Biosergen A/S
Clanotech AB
Cytoguide
DermaGen AB
Dilafor AB
Eribis Pharmaceuticals AB
HBV Theranostica AB
IMED AB
Independent Pharmaceutica AB
InDex Pharmaceuticals AB
Inhalation Sciences Sweden AB
Lipopeptide AB
NeoDynamics AB
NephroGenex Inc.
NeuroTherapeutics AB
NovaSAID AB
Omnio Healer AB
Oncopeptides AB
Pergamum AB
PharmaSurgics AB
Promimic AB
ProNoxis AB
Umecrine AB
Umecrine Cognition AB
Umecrine Mood AB
XSpray Microparticles AB